Safety and Efficacy Evaluation of PerkinRA in Comparison with Kineret in Systemic Juvenile Idiopathic Arthritis Patients

A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19

Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18–60 years: A double-blind, non-inferiority, randomized controlled trial

Immunogenicity and safety evaluation of a newly manufactured recombinant Baculovirus-Expressed quadrivalent influenza vaccine in adults 18 years old and Above: An Open-Label, phase III extension study

Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirhttps://pubmed.ncbi.nlm.nih.gov/35352698/us vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trial